Clinical symptoms and QoL significantly improved from baseline to day 21 in both groups ( p < .001 for VAS , Lowenberg test , thrombus length , and erythema ; p < .006 for QoL ) , and consumption of analgesics and D-dimer significantly decreased ( p < .001 ) .